.jpg)
Tom joined miDiagnostics in April 2020 to lead System Architecture on the Complete Blood Count product, in May 2021 he took up the role of VP Product Development. He has extensive experience successfully developing products for markets across a range of industries. Tom is a Chartered Mechanical Engineer, holds a master’s degree in Mechanical and Design Engineering from University of Newcastle-Upon-Tyne, and is a Fellow of the IMechE. Prior to miDiagnostics Tom was System Development Lead for a point-of-care diagnostic instrument with QuantuMDx, and led a global New Product Development team with National Oilwell Varco.
Richard is a biochemist and molecular biologist and has worked in the in vitro diagnostics sector for the past 10 years, during which time he established and built up the UK operations of AusDiagnostics. Prior to this Richard worked in Biotech (Cellzome) for ten years and Drug Discovery (Glaxo) for thirteen years.
.jpg)
Professor Paul Verweij is head of the Medical Microbiology department, which deals with the prevention, diagnostics, and treatment of infectious diseases, especially those of patients admitted to the Radboud university medical center. Verweij is the chairman of the Nijmegen University Centre for Infectious Diseases (NUCI), a leading organization combining patient care, education, and research in the field of infectious diseases. Verweij's research focuses on the detection and treatment of fungal infections in patients with greatly reduced resistance to infections. This research has aided the improved and earlier detection of these fatal infections.
Dr Satta is a consultant in infection and the infection control doctor at University College Hospitals/honorary Associated Professor at UCL.
He began his medical training in Italy before coming to the UK to study at the London School of Hygiene and Tropical Medicine. He then undertook specialist training in both infectious diseases and microbiology. He was also an academic fellow at UCL where he completed a PhD on whole genome sequencing and M. tuberculosis. He also holds an MBA in Healthcare, a Master of Public Health, the DTM&H and he is board certified in infection and prevention control (CIC).
Dr. Jens Ducrée holds a Full Professorship of Microsystems in the School of Physical Sciences at Dublin City University (DCU). He is the founding director of FPC@DCU – Ireland’s first Fraunhofer Project Centre for Embedded Bioanalytical Systems, a joint initiative of Science Foundation Ireland and Fraunhofer-Gesellschaft. The main part of his research is directed towards novel microfluidic systems and associated actuation, detection, fabrication and instrumentation technologies for the integration, automation, miniaturization, and parallelization of bioanalytical. Typical applications of these next-generation “Lab-on-a-Chip” platforms are sample-to-answer systems for biomedical point-of-care and global diagnostics, liquid handling automation for the life sciences, process analytical techniques and cell line development for biopharma as well as monitoring the environment, infrastructure, industrial processes and agrifood.
Peter is a Clinical Lead, Microbiologist in University Hospitals of Coventry and Warwickshire NHS Trust and Trust Clinical Lead for antimicrobial stewardship with a great track history of continuous clinical service mprovements in tertiary healthcare. He is skilled in formation and leading highly functional and agile clinical teams. He is an accomplished and GMC certified medical educator, coach and mentor and enjoys teaching.
Vanya Gant is an academic clinician with a PhD in Cellular Immunology. He is qualified in Microbiology and Infectious Diseases and Divisional Clinical Director for Infection at UCLH, having also led UCLH Pathology for several years and contributed to the core concepts, values and delivery of HSL.
He leads the Clinical infection service for UCLH’s large haematological malignancy Division and innovates and drives several strategic development projects for UCLH Trust.
He co-authored a book on Artificial Neural Networks in Clinical Medicine, was Principal Clinical Investigator for a novel “sample in/answer out” bacterial/viral detection platform currently undergoing EU accreditation and is Co-Principal Investigator for an innovative NIHR Programme grant on antimicrobial resistance. He has a keen interest in industry pull through from Academic innovation and advises the UK’s Technology Strategy Board (now Innovate UK) and several large academic research consortia in the UK and abroad. He founded and directs two Infection Management companies.
He is particularly proud of contributing to the development of the UK’s Find and Treat service, a unique mix of mobile diagnostics and innovative healthcare delivery for the UK’s poorest, and of being a Trustee for the Pathway Charity for the Homeless.
Willem Melchers is an associate professor Research interests are in molecular microbiology, with a specific focus on the relationship between HPV infections and the development of cervical cancer. Current studies of him are focusing on the secondary factors related to progression from subclinical infection to invasive cervical cancer. His interests include novel interdisciplinary approaches where molecular biology and genetics are tightly coupled with (bio) physical/informatics methods aimed at understanding the biological function at a molecular level. Willem Melchers is associate professor in Molecular Microbiology. He is head of the Laboratory of Clinical Microbiology of the department of Medical Microbiology.
Eric C.J. Claas has a long-standing experience in implementation of innovative molecular tests in the clinical microbiology laboratory. After his PhD in 1991, he worked for eight years at the Dutch National Influenza centre (Erasmus University, Rotterdam) where his group identified the first human H5N1 (bird-flu) infection in 1997.Since 1998, he is heading the molecular diagnostics section of the department of medical microbiology at the LUMC, Leiden, The Netherlands. More than 100 real-time PCR assays are being offered under compliance of the ISO15189 guidelines. He is coordinator of the NGS activities of the department and also acts as a consultant for molecular diagnostics at the Franciscus Gasthuis and Vlietland hospital in Rotterdam, The Netherlands. He has authored over 200 peer reviewed publications and books and holds several positions in societies and committees.
Like all the other healthcare providers, laboratory personnel have been working above and beyond during this COVID-19 pandemic. One such scientist, Miss Reshma Kadave, was part of the core team of biomedical scientists and associate practitioners to set up and produce quite an astonishing response to support this massive extra ask by the NHS. Reshma qualified as a Biomedical Scientist from Kingston University, London, 2008. Since then, she has been actively involved in diagnostic testing at Imperial College Healthcare NHS Trust, Department of Infection and Immunity. In 2020, she faced her biggest challenge which involved the interfacing of POCT instruments across the different sites for the Trus
